A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer

2021 ◽  
Author(s):  
Margaret M. Lubas ◽  
Belinda N. Mandrell ◽  
William L. Greene ◽  
Carrie R. Howell ◽  
Robbin Christensen ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Survivors Of Childhood Cancer

A randomized, double-blind, placebo-controlled trial of methylphenidate for attentional problems in survivors of childhood cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8510-8510 ◽  
Author(s):  
R. K. Mulhern ◽  
R. Khan ◽  
S. Kaplan ◽  
X. Xiong ◽  
S. Wu ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Survivors Of Childhood Cancer

A randomized, double-blind, placebo-controlled trial of methylphenidate for attentional problems in survivors of childhood cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 8510-8510
Author(s):  
R. K. Mulhern ◽  
R. Khan ◽  
S. Kaplan ◽  
X. Xiong ◽  
S. Wu ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Survivors Of Childhood Cancer

scholarly journals Predicting Methylphenidate Response in Long-Term Survivors of Childhood Cancer: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

2009 ◽  
Vol 35 (2) ◽  
pp. 144-155 ◽  
Author(s):  
H. M. Conklin ◽  
S. Helton ◽  
J. Ashford ◽  
R. K. Mulhern ◽  
W. E. Reddick ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Crossover Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Survivors Of Childhood Cancer ◽  
Long Term Survivors

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

1997 ◽  
Vol 27 (8) ◽  
pp. 860-867 ◽  
Author(s):  
V.A. VARNEY ◽  
J. EDWARDS ◽  
K. TABBAH ◽  
H. BREWSTER ◽  
G. MAVROLEON ◽  
...  
Keyword(s):  
Clinical Efficacy ◽  
Specific Immunotherapy ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

2001 ◽  
Vol 120 (5) ◽  
pp. A384-A384
Author(s):  
L MOLLISON ◽  
L TOTTEN ◽  
C HOVELL ◽  
K THAYNE ◽  
C CONNELLY ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Controlled Trial ◽  
Herbal Preparation ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Chinese Herbal

40: Oral Ketoconazole for Prevention of Postoperative Penile Erection, a Prospective, Randomized, Double Blind, Placebo Controlled Trial

2007 ◽  
Vol 177 (4S) ◽  
pp. 14-15
Author(s):  
Brian J. DeCastro ◽  
Jack R. Walter ◽  
Leah P. McMann ◽  
Andrew C. Peterson
Keyword(s):  
Penile Erection ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Effects of Mixed Dietary Supplements on Total Plasma Homocysteine Concentrations (tHcy): A Randomized, Double-Blind, Placebo-Controlled Trial

2012 ◽  
Vol 82 (4) ◽  
pp. 260-266 ◽  
Author(s):  
Salah E. Gariballa ◽  
Sarah J. Forster ◽  
Hilary J. Powers
Keyword(s):  
Older Patients ◽  
Controlled Trial ◽  
Plasma Homocysteine ◽  
Acute Illness ◽  
Vitamin B ◽  
Total Plasma ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Nutrient Supplement ◽  
Plasma Thcy

Background: Although a number of studies have reported raised total plasma homocysteine (tHcy) concentrations in free-living older people, there are no data on homocysteine response to a mixed nutrient supplement in older patients. A raised plasma homocysteine concentration in older patients is partly a reflection of their co-morbidity, including impaired renal function, and there is uncertainty about the extent to which dietary interventions can improve plasma tHcy. Aim: To determine the plasma tHcy response to dietary supplements during acute illness. Methods: Two-hundred and thirty-six hospitalized, acutely ill older patients, who were part of a randomized double-blind placebo-controlled trial, were assigned to receive a daily oral nutritional supplement drink containing 1.3 mg of vitamin B2, 1.4 mg of vitamin B6, 1.5 μg of B12, 200 μg of folic acid, or a placebo, for 6 weeks. Outcome measures were plasma tHcy concentration at baseline, 6 weeks, and 6 months. Results: The mean plasma tHcy concentration fell among patients given the supplements (mean difference 4.1 µmol/L [95 % C.I, 0.14 to 8.03), p = 0.043], but tHcy concentration increased between 6 weeks and 6 months, after patients stopped taking the supplements [mean difference -2.0 µmol/L (95 % C.I, -03.9 to -0.18), p = 0.033]. About 46 % of patients in the placebo group and 55 % of patients in the supplement group had hyperhomocysteinemia (>14 µmol/L) at baseline compared with 45 % and 29 % at the end of the treatment period. Conclusions: A mixed nutrient supplement containing physiological amounts of B vitamins significantly reduced plasma tHcy concentrations in older patients recovering from acute illness.

Sign in / Sign up

Export Citation Format

Share Document